Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiromasa Yamauchi is active.

Publication


Featured researches published by Hiromasa Yamauchi.


Journal of Infection and Chemotherapy | 2011

Leuconostoc bacteremia in three patients with malignancies

Ken Ishiyama; Hirohito Yamazaki; Yasuko Senda; Hiromasa Yamauchi; Shinji Nakao

Leuconostoc is a Gram-positive coccus characterized by its resistance to glycopeptide antibiotics. Generally, this bacterium is susceptible to β-lactam antibiotics; however, here we present a leukemia patient who developed leuconostoc bacteremia during antimicrobial therapy with carbapenem. The appropriate choice of antibiotics at optimal doses enables leuconostoc infection to be overcome, even in compromised hosts. We report 3 cases of leuconostoc bacteremia: the leukemia case which was successfully treated, along with discussions of two other cases with malignancies.


British Journal of Haematology | 2001

Non‐myeloablative stem cell transplantation for accelerated‐phase chronic myeloid leukaemia: circumvention of graft rejection with donor leucocyte infusion early after transplantation

Akiyoshi Takami; Tatsuya Chuhjo; Xingmin Feng; Yukio Kondo; Hiromasa Yamauchi; Shizuka Yasue; Shintaro Shiobara; Shinji Nakao

Keywords: accelerated phase; chronic myeloid leukaemia; non-myeloablative stem cell transplantation; donor leucocyte infusion; fluorescence in situ hybridization


International Journal of Hematology | 1999

Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog.

Akiyoshi Takami; Shinji Nakao; Yasuo Ontachi; Hiromasa Yamauchi; Tamotsu Matsuda


International Journal of Hematology | 2002

Tsutsugamushi Disease (Scrub Typhus)—Associated Hemophagocytic Syndrome

Akiyoshi Takami; Hiromasa Yamauchi; Hidesaku Asakura; Ken Ishiyama; Shinji Nakao


International Journal of Hematology | 1997

Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony stimulating factor.

Hirokazu Okumura; Takashi Yoshida; Hideyuki Takamatsu; Tsutomu Katoh; Makoto Murashima; Akiharu Watanabe; Hiromasa Yamauchi; Sadaya Matano; Tatsuya Chuhjo; Minoru Takeshima; Hiroyasu Kaya; Shigeki Ohtake; Shinobu Nakamura; Tamotsu Matsuda


Japanese Journal of Medicine | 1986

Methionine Partially Corrects the Impaired Deoxyribonucleic Acid Synthesis of B12-deficient Megaloblastic Bone Marrow Cells at Low Concentration

Masamitsu Karasawa; Hiromasa Yamauchi; Mitsuhiro Omine; Tadashi Maekawa


International Journal of Hematology | 1996

Elevated deoxyuridine triphosphate nucleotidohydrolase (dUTPase) activity in the cobalamin-deficient megaloblastic bone marrow cells.

Yutaka Sugita; Hiromasa Yamauchi; Mitsuhiro Omine; Tadashi Maekawa


Japanese journal of geriatrics | 2001

[Low dose melphalan therapy was effective in an elderly patient with MDS-AML].

Yasuo Ontachi; Hiromasa Yamauchi; Akiyoshi Takami; Hidesaku Asakura; Shinji Nakao


The Kitakanto Medical Journal | 1989

A METABOLIC MODEL FOR THE MEGALOBLASTIC ANEMIA USING IN VITRO L1210 CELL CULTURE SYSTEM

Hiroshi Yatabe; Hiromasa Yamauchi; Masamitsu Karasawa; Mitsuhiro Omine; Tadashi Maekawa


The Japanese journal of clinical hematology | 1989

Urinary methylmalonic acid excretion and clinical features in megaloblastic anemia due to vitamin B12 deficiency

Hiromasa Yamauchi; Mitsuhiro Omine; Norifumi Tsukamoto; Katahira H; Masamitsu Karasawa; Sugita Y; Yatabe H; Iwata N; Tadashi Maekawa

Collaboration


Dive into the Hiromasa Yamauchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge